Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 11;2(5):525-32.
doi: 10.1242/bio.20133715. Print 2013 May 15.

Integrin αIIb (CD41) plays a role in the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta

Affiliations

Integrin αIIb (CD41) plays a role in the maintenance of hematopoietic stem cell activity in the mouse embryonic aorta

Jean-Charles Boisset et al. Biol Open. .

Abstract

Integrins are transmembrane receptors that play important roles as modulators of cell behaviour through their adhesion properties and the initiation of signaling cascades. The αIIb integrin subunit (CD41) is one of the first cell surface markers indicative of hematopoietic commitment. αIIb pairs exclusively with β3 to form the αIIbβ3 integrin. β3 (CD61) also pairs with αv (CD51) to form the αvβ3 integrin. The expression and putative role of these integrins during mouse hematopoietic development is as yet unknown. We show here that hematopoietic stem cells (HSCs) differentially express αIIbβ3 and αvβ3 integrins throughout development. Whereas the first HSCs generated in the aorta at mid-gestation express both integrins, HSCs from the placenta only express αvβ3, and most fetal liver HSCs do not express either integrin. By using αIIb deficient embryos, we show that αIIb is not only a reliable HSC marker but it also plays an important and specific function in maintaining the HSC activity in the mouse embryonic aorta.

Keywords: Aorta; CD41; Fetal liver; Hematopoietic stem cells; Integrin; Mouse development; Placenta.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors have no competing interests to declare.

Figures

Fig. 1.
Fig. 1.. Phenotypic and functional analyses of integrin-based sorted cell fractions.
(A,C,E,G) Flow cytometric analyses of E11 Aorta–Gonad–Mesonephros (AGM), E12 yolk sac (YS), E12 placenta (PL) and E14 fetal liver (FL). Representative sorting gates of each population are indicated. (B,D,F,H) Hematopoietic repopulation analyses after injection of integrin-based sorted fractions of AGM (n = 2), YS (n = 4), PL (n = 2) and FL (n = 3). Numbers above columns indicate number of mice repopulated/number of mice injected. Dose of injected cells is indicated as embryo equivalent (ee).
Fig. 2.
Fig. 2.. Location of phenotypically defined HSCs in AGM and placenta.
(A) Intra-aortic hematopoietic clusters (IAHCs) of E10.5 wild-type embryos. Non-fixed embryo slices were stained with antibodies against CD51 (αv), CD41 (αIIb) and CD61 (β3). Scale bars: 10 µm. (B) Non-fixed placenta slices (E12) were stained with antibodies against Tie-2. Transmitted light and fluorescent images are merged. Scale bar: 100 µm. (C) Confocal stack image of an E12 non-fixed placenta slice stained with antibodies against CD51, CD61 and Tie-2. Close up of the boxed area (left panel) shows a group of labelled cells (single and merged fluorescent channels are shown). Scale bars: 10 µm. UA: umbilical artery, C: chorionic plate, L: labyrinth, S: spongiotrophoblast layer, FV: fetal vessel.
Fig. 3.
Fig. 3.. Intra-aortic hematopoietic clusters and in vitro clonogenic progenitor activity of AGM cells isolated from E11 CD41 (αIIb) deficient embryos.
(A) In vitro clonogenic analyses. AGMs were isolated from E11 wild-type (αIIb+/+), heterozygous (αIIb+/tk) or homozygous deficient embryos (αIIbtk/tk). Error bars: standard deviations for n = 3 independent experiments. CFU-GEMM: CFU-Granulocyte–Erythroid–Macrophage–Megakaryocyte; CFU-GM: CFU-Granulocyte–Macrophage; CFU-M: CFU-Macrophage; CFU-G: CFU-Granulocyte; BFU-E: Burst-Forming Unit-Erythroid. (B) Number of c-kit+ cells per E11 αIIb+/+ (n = 5 embryos), αIIb+/tk (n = 5 embryos) and αIIbtk/tk (n = 3 embryos) aorta. Error bars: standard deviations. Confocal stack images of the mouse aorta region of E11 αIIb+/+ (C) and αIIbtk/tk (D) embryos after whole mount staining for c-kit and CD31. Scale bars: 50 µm. ns: not statistically significant. Error bars: standard deviations.
Fig. 4.
Fig. 4.. Functional analyses of AGM, yolk sac and fetal liver cells isolated from E11 CD41 (αIIb) deficient embryos.
Hematopoietic repopulation analysis of mice after injection of (A,B) AGM, (C) yolk sac or (D) fetal liver cells isolated from E11 wild-type (αIIb+/+), heterozygous (αIIb+/tk) or homozygous deficient embryos (αIIbtk/tk). (A,B) Percentage of chimerism in peripheral blood for each injected mice. Lozenge: one transplanted mouse. Red lozenge: mice used to perform secondary transplantations. Dashed line: limit of positivity (>10% of chimerism). Red line: chimerism average. (A) AGM cells were injected directly (n = 3) or (B) after explant culture (n = 3). The genotype of embryos, the number of mice repopulated/number of mice transplanted (# Rep./# Inj.) and the percentage of repopulated mice (% Rep.) are indicated below the graphs. 1 embryo equivalent (ee) of AGM cells was injected per recipient (n = 3). p-values are indicated. (C,D) Percentage of repopulated mice. Numbers below columns: number of mice repopulated/number of mice transplanted. (C) 1 ee of yolk sac cells (n = 3) and (D) 3 to 4.5 ee of fetal liver cells (n = 4) were injected per recipient. Due to the very low number of HSCs in E11 FL, αIIb+/tk and αIIbtk/tk cells were pooled. ns: not statistically significant.
Fig. 5.
Fig. 5.. Functional analyses of E14 fetal liver cells isolated from CD41 (αIIb) deficient embryos.
Hematopoietic repopulation analysis of mice after the injection of fetal liver cells isolated from E14 wild-type (αIIb+/+; grey bars), heterozygous (αIIb+/tk; dark grey bars), or homozygous deficient (αIIbtk/tk; black bars embryos. Numbers above columns: number of mice repopulated/number of mice transplanted.

References

    1. Boisset J. C., Robin C. (2012). On the origin of hematopoietic stem cells: progress and controversy. Stem Cell Res. 8, 1–13 10.1016/j.scr.2011.07.002 - DOI - PubMed
    1. Boisset J. C., van Cappellen W., Andrieu–Soler C., Galjart N., Dzierzak E., Robin C. (2010). In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464, 116–120 10.1038/nature08764 - DOI - PubMed
    1. Boisset J. C., Andrieu–Soler C., van Cappellen W. A., Clapes T., Robin C. (2011). Ex vivo time-lapse confocal imaging of the mouse embryo aorta. Nat. Protoc. 6, 1792–1805 10.1038/nprot.2011.401 - DOI - PubMed
    1. Bonig H., Priestley G. V., Wohlfahrt M., Kiem H. P., Papayannopoulou T. (2009a). Blockade of alpha6-integrin reveals diversity in homing patterns among human, baboon, and murine cells. Stem Cells Dev. 18, 839–844 10.1089/scd.2008.0269 - DOI - PMC - PubMed
    1. Bonig H., Watts K. L., Chang K. H., Kiem H. P., Papayannopoulou T. (2009b). Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization. Stem Cells 27, 836–837 10.1002/stem.9 - DOI - PMC - PubMed

LinkOut - more resources